Total Payments
$645.83
2024 Payments
$208.46
Companies
15
Transactions
39
Medicare Patients
878
Medicare Billing
$47,709
Payment Breakdown by Category
Food & Beverage$645.83 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $645.83 | 39 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Hologic, LLC | $139.81 | 8 | $0 (2020) |
| ABBVIE INC. | $117.31 | 7 | $0 (2024) |
| Astellas Pharma US Inc | $100.66 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $60.85 | 5 | $0 (2019) |
| MILLICENT US INC | $34.50 | 2 | $0 (2024) |
| Smith+Nephew, Inc. | $31.78 | 2 | $0 (2024) |
| Organon Llc | $30.52 | 2 | $0 (2024) |
| Gynesonics, Inc. | $28.31 | 2 | $0 (2024) |
| TherapeuticsMD, Inc. | $18.17 | 1 | $0 (2022) |
| PFIZER INC. | $16.61 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $208.46 | 10 | Astellas Pharma US Inc ($100.66) |
| 2023 | $15.51 | 1 | Organon LLC ($15.51) |
| 2022 | $126.30 | 8 | ABBVIE INC. ($56.18) |
| 2020 | $31.66 | 1 | Hologic, LLC ($31.66) |
| 2019 | $24.00 | 2 | Merck Sharp & Dohme Corporation ($24.00) |
| 2018 | $161.58 | 12 | Hologic, LLC ($69.94) |
| 2017 | $78.32 | 5 | HOLOGIC INC ($38.21) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: PAIN | ||||||
| 08/13/2024 | Smith+Nephew, Inc. | STRAVIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Extra Cellular Matrix | ||||||
| 08/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Biological | ||||||
| 06/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: Biological | ||||||
| 06/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.48 | General |
| Category: Biological | ||||||
| 04/09/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 03/19/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.34 | General |
| Category: Biological | ||||||
| 02/06/2024 | Gynesonics, Inc. | SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.57 | General |
| Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM | ||||||
| 02/01/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: NEUROSCIENCE | ||||||
| 01/04/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.01 | General |
| Category: ETONOGESTREL | ||||||
| 03/23/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: ETONOGESTREL | ||||||
| 12/23/2022 | MILLICENT US INC | INTRAROSA (Drug), FEMRING | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: TREATMENT OF DYSPAREUNIA | ||||||
| 11/15/2022 | MAYNE PHARMA INC. | — | Food and Beverage | In-kind items and services | $15.04 | General |
| 10/20/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: WOMENS HEALTH | ||||||
| 10/12/2022 | Gynesonics, Inc. | SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) | Food and Beverage | In-kind items and services | $12.74 | General |
| Category: SONATA TRANSCERVICAL FIBROID ABLATION SYSTEM | ||||||
| 10/10/2022 | ABBVIE INC. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: WOMENS HEALTH | ||||||
| 09/01/2022 | TherapeuticsMD, Inc. | ANNOVERA (Drug), BIJUVA, IMVEXXY | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: OBSTETRICS GYNECOLOGY WOMEN'S HEALTH | ||||||
| 06/16/2022 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: WOMENS HEALTH | ||||||
| 04/05/2022 | Meditrina | Aveta (Device) | Food and Beverage | Cash or cash equivalent | $11.74 | General |
| Category: Gynecology | ||||||
| 01/08/2020 | Hologic, LLC | Fluent (Device) | Food and Beverage | In-kind items and services | $31.66 | General |
| Category: Surgical | ||||||
| 10/17/2019 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $11.33 | General |
| 07/18/2019 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL9 | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: WOMENS HEALTH | ||||||
| 12/07/2018 | Hologic, LLC | Myosure (Device) | Food and Beverage | In-kind items and services | $14.26 | General |
| Category: Surgical | ||||||
| 12/06/2018 | Merck Sharp & Dohme Corporation | NEXPLANON (Drug), GARDASIL9 | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: WOMENS HEALTH | ||||||
| 12/05/2018 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 238 | 245 | $61,380 | $13,928 |
| 2022 | 5 | 230 | 236 | $52,846 | $11,846 |
| 2021 | 5 | 230 | 240 | $52,210 | $12,490 |
| 2020 | 5 | 180 | 184 | $38,298 | $9,444 |
Total Patients
878
Total Services
905
Medicare Billing
$47,709
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77067 | Screening mammography | Office | 2023 | 45 | 45 | $27,000 | $5,084 | 18.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 81 | 81 | $10,845 | $3,127 | 28.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 34 | $8,636 | $2,103 | 24.4% |
| 77063 | Screening 3d breast mammography | Office | 2023 | 45 | 45 | $8,730 | $1,959 | 22.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 40 | 40 | $6,169 | $1,654 | 26.8% |
| 77067 | Screening mammography | Office | 2022 | 43 | 43 | $25,800 | $3,992 | 15.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 69 | 69 | $8,280 | $2,724 | 32.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 51 | 51 | $6,120 | $2,154 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 23 | 29 | $7,366 | $1,811 | 24.6% |
| 77063 | Screening 3d breast mammography | Office | 2022 | 44 | 44 | $5,280 | $1,165 | 22.1% |
| 77067 | Screening mammography of both breasts | Office | 2021 | 39 | 39 | $23,400 | $3,886 | 16.6% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 68 | 68 | $8,160 | $2,676 | 32.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 59 | 59 | $7,080 | $2,523 | 35.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 35 | $8,890 | $2,202 | 24.8% |
| 77063 | Screening digital tomography of both breasts | Office | 2021 | 39 | 39 | $4,680 | $1,204 | 25.7% |
| 77067 | Mammography of both breasts | Office | 2020 | 29 | 29 | $16,080 | $3,135 | 19.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 56 | 56 | $6,720 | $2,273 | 33.8% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 42 | 42 | $5,040 | $1,776 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 23 | 27 | $6,858 | $1,208 | 17.6% |
| 77063 | Screening digital tomography of both breasts | Office | 2020 | 30 | 30 | $3,600 | $1,052 | 29.2% |
About Dr. Melissa Moore, MD
Dr. Melissa Moore, MD is a Obstetrics healthcare provider based in Winter Park, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740282466.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Moore, MD has received a total of $645.83 in payments from pharmaceutical and medical device companies, with $208.46 received in 2024. These payments were reported across 39 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($645.83).
As a Medicare-enrolled provider, Moore has provided services to 878 Medicare beneficiaries, totaling 905 services with total Medicare billing of $47,709. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Obstetrics
- Other Specialties Obstetrics & Gynecology
- Location Winter Park, FL
- Active Since 08/12/2005
- Last Updated 06/23/2023
- Taxonomy Code 207VX0000X
- Entity Type Individual
- NPI Number 1740282466
Products in Payments
- Veozah (Drug) $100.66
- NEXPLANON (Drug) $67.83
- Novasure (Device) $61.64
- Myosure (Device) $46.51
- Fluent (Device) $31.66
- Orilissa (Drug) $31.22
- LO LOESTRIN FE (Drug) $30.86
- SONATA SONOGRAPHY-GUIDED TRANSCERVICAL FIBROID ABLATION SYSTEM (Device) $28.31
- LILETTA (Drug) $25.32
- FEMRING (Drug) $22.07
- STRAVIX PL (Medical Supply) $20.00
- UBRELVY (Drug) $18.54
- ANNOVERA (Drug) $18.17
- NURTEC ODT (Drug) $16.61
- ENDOMETRIAL ABLATION SYSTEM (Device) $14.70
- CERVIDIL (Drug) $13.20
- Endosee (Device) $12.63
- INTRAROSA (Drug) $12.43
- PICO (Device) $11.78
- Aveta (Device) $11.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.